4 Medical Reasons Why Precise Weighing Scales Should be Used

In the field of medicine, accuracy and precision play a crucial role. Whether it’s for patient care, medication dosing, nutritional management, or research purposes, using precise weighing scales is vital.

So, what are the implications of wrong weighing scales? And why accurate weighing scale is so important in the medical field? 

In 2015, the National Measurement and Regulation Office (NMRO) conducted a comprehensive assessment to evaluate the suitability of weighing scales used in various healthcare settings, including GP surgeries, health centers, health visitors, and pharmacies.

The report highlighted the importance of utilizing a precise and certified scale in medical environments and stated an incorrect reading can result in the patient receiving the wrong treatment and medication, leading to serious or fatal consequences.

If you are still wondering about the relevance of accurate weighing scales in the medical field, delve into this article. We will explore four reasons why precise weighing scales should be used and how they play a vital role in improving patient outcomes and overall healthcare quality.

It Can Be a Matter of Life and Death

Getting accurate and consistent weight readings for patients could be a matter of life and death. To get a better understanding, you need to think of the purpose of weighing patients.

Generally, it is not done just to record their weight but for making some crucial medical decisions, such as calculating accurate medication dosages, anesthesia administration, or radiation therapy planning.

According to the National Medical Weighing Project, approximately one-third of scales used in medical settings were found to be inaccurate. While some of these errors may have minimal consequences, such as when monitoring adult obesity. However, accuracy becomes critical when weighing a premature newborn to determine drug dosages.

Monitoring Weight Changes

Managing the weight of the patient is very critical in various medical conditions like kidney diseases, eating disorders, and heart-related problems. A small variation in weight can be an early indicator of health issues.

With accurate weight scales, healthcare providers will be able to monitor even the subtle changes in the weight of patients. This will enable them to intervene at the right time and adjust the treatment plans, including their diet and exercises, accordingly.

Accessing Nutritional Status

In the field of clinical medicine, nutritional assessment serves three key objectives: first, to recognize and classify the existence of malnutrition; second, to determine the presence of obesity that poses a threat to health; and third, to develop appropriate dietary plans as a preventive measure against potential diseases in the future.

Thus, by conducting nutritional assessments, patients and healthcare providers have a comprehensive understanding of their health and nutritional status.

It provides valuable insights into the overall well-being of the body, encompassing nutrition, dietary habits, and weight. And with precise weighing scales, healthcare providers will be able to do accurate nutritional assessments and plan correct interventions.

Patients Are Assured

By using a precise weighing scale, patients will feel reassured that they are in safe hands and are receiving excellent care. Most probably, a patient might already be familiar with their weight, having been weighed during previous doctor’s visits or other medical assessments.

Thus, providing accurate weight can foster trust between the healthcare provider and the patient, which can improve the overall patient experience.

Conclusion

The use of accurate weighing scales in the medical field is a critical necessity to provide quality health care to patients. Precise weight reading plays a major role in accurate diagnosis, appropriate medicine dosage, and proper treatment plans. 

So, it is recommended to do regular calibration checks to maintain the scales’ accuracy and compliance with industry standards to improve the quality of healthcare.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”